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Tracheotomy, through its ability to wean patients off ventilation, can shorten ICU length of 
stay and in doing so increase ICU bed capacity, crucial for saving lives during the COVID-19 
pandemic. To date, there is a paucity of patient selection criteria and prognosticators to 




Prospective study of COVID-19 patients undergoing tracheotomy (n=12) over a 4-week 
period (March-April 2020). Association between pre- and post- operative ventilation 




Patients who sustained FiO2≤50% and PEEP≤8cm H2O in the 24h pre-tracheotomy exhibited 
a favourable outcome. Those whose requirements remained below these thresholds post-




Sustained FiO2≤50% and PEEP≤8cm H2O in the 48h post-tracheotomy are strong predictive 
factors for a good outcome, raising the potential for these patients to be stepped down 







Coronavirus disease 2019 (COVID-19) has rapidly evolved into a pandemic since the first 
report emerged from China in December 2019 1. With the number of cases rising globally at 
an exponential rate and with over 10% of these requiring Intensive Care Unit (ICU) 
admission, demand for critical care increasingly threatens to exceed capacity even among 
the world’s most advanced economies 2. At present, supportive treatment forms the basis 
of therapy, with trials currently ongoing to unearth the optimal medicinal treatment 
regimen and vaccine. Tracheotomy, through its ability to wean patients off ventilation, can 
shorten the ICU length of stay and in doing so increase ICU bed capacity; crucial for saving 
lives at a population level. 3,4 Median ICU stay for COVID-19 patients varies widely between 
countries ranging between 4 to over 20 days. 5  
 
Tracheotomy constitutes an Aerosol Generating Procedure (AGP), thus potentially exposing 
the operating surgeon and Operating Room (OR) team to respiratory droplets from the 
SARS-CoV-2 infected patient 6. With this added risk in mind it is vital that the potential 
benefits of a reduced ICU stay associated with performing a tracheotomy are balanced 
against the risks to healthcare professionals. Despite a number of authors having already 
published guidelines to minimize risks to healthcare personnel when performing 
tracheotomy in the COVID-19 positive patient7-11, there is currently a paucity of literature on 
patient selection criteria for this procedure and outcomes data for patients who have 
undergone tracheotomy in these circumstances. To address this, we present our data from 
the first 12 COVID-19 patients that underwent tracheotomy in our institution, and propose 
parameters to inform patient selection by identifying those patients who may be more likely 
to benefit from the procedure. Furthermore, we discuss potential predictive factors that 
may help clinicians identify at an early stage (48h post-operatively) those patients who are 
likely to have a positive outcome post-tracheotomy, which may facilitate decisions to step-
down patient care and thus improve the availability of critical care resources to those 






This was a prospective study of all COVID-19 patients undergoing tracheotomy (n=12) in a 
Head & Neck Unit in the United Kingdom during a 4-week period (March-April 2020). 
Anesthesiological processes and surgical steps pre- and peri-tracheostomy insertion were 
standardised to minimise risk to staff and improve patient safety during this crucial part of 
the procedure (see Supplementary Material).  Recordings of the patient’s Fraction of 
Inspired Oxygen (FiO2) and Peak End Expiratory Pressure (PEEP) were obtained for the 24 
hours preceding the procedure, and subsequently collected on a daily basis until the patient 
was either decannulated and discharged from hospital, or died.  Fluctuations in these 
values, which occurred due to patient intervention/movement were removed in order to 
facilitate calculation of representative averages for these values.  The number of days that 
patients were kept under sedation and number of days taken for decannulation were also 
recorded.  
 
Following our experience with our first 5 tracheotomies and in accordance with our local 
protocol (see Supplementary Material) and published literature 7–9,we instituted selection 
criteria for all subsequent tracheotomies as follows: 
 
• Patients should ideally be at least 14 days post-positive swab result 
• Low oxygen requirements (FiO2≤40%), sustained for at least 24 hours 
• Patient able to tolerate clamped tube for 1 min in ICU (‘clamp test’) 
• Two failed trials of sedation withholding prior to considering tracheotomy 
• Patients that will not require prone ventilation 
 
Correlation between data sets was determined using the ‘R’ statistical software (v3.6.1, © 
The R Foundation, Vienna, Austria). Data were ranked, and Spearman’s rank correlation 
coefficient was calculated to determine association between data sets.  
Results  
In total, 12 COVID-19 patients underwent surgical tracheotomy over a 4-week period 
(March-April 2020), of which two died (patients B and C). Patient B had FiO2 values ranging 
between 81-90% in the 24 hours before tracheotomy, whilst patient C had their 
tracheotomy performed 4 days after having a positive swab result. Of the remaining 
patients that survived, patients D and E took the longest to be decannulated, both of whom 
had pre-operative FiO2 values ≥50%, as well as high PEEP values (Table 1). 
 
The data suggest that a patient’s pre-operative status in the 24 hours preceding the 
procedure may highlight those patients likely to benefit from tracheotomy. Figure 1 
illustrates each patient’s pre-operative FiO2 concentration and PEEP requirements in the 
format of a bubble plot, which suggests that an FiO2 of ≥50% with a PEEP of ≥8cm of H2O in 
the 24 hours preceding tracheotomy may be associated with a worse outcome, as the 
patients that did not fulfil these criteria in the 24 hours preceding tracheotomy either died 
or had a prolonged wean of ventilation despite the procedure.  
 
Cumulative data suggested that patients requiring an FiO2 of ≤50% and PEEP of ≤8cm of H2O 
in the first 48 hours following tracheotomy tended to have a more favorable outcome 
compared to those exceeding these values. To examine this in greater depth, the proportion 
of time for each patient at which the PEEP was ≥8cm H20 and the proportion of time FiO2 
was ≥50% across all days were calculated regardless of length of follow-up. From this, the 
average proportion of time that PEEP was ≥8cm H20 and average proportion of time that 
FiO2≥50% were calculated, with the patients subsequently ranked accordingly. These steps 
were then repeated but with only looking at the data for up to day 2 post-tracheotomy to 
look for early prognostic indicators (see Supplementary Figures 1 and 2). The ranks for both 
parameters were then plotted on a scatter plot (Figure 2), which illustrates that rank at day 
2 post-tracheotomy strongly correlates with rank from all days, and therefore with the 




This is the first report of patient outcomes following tracheotomy in COVID-19 patients, and 
on the basis of our institutional experience we propose criteria that offer a pragmatic 
solution to facilitate patient care whilst minimizing risks to healthcare workers.  
 
Given the risk that tracheotomy in COVID-19 patients poses to healthcare workers through 
aerosolization of SARS-CoV-2 virions, it is paramount that these risks are carefully balanced 
against potential benefits to patient care. Concerns around infection in COVID-19 patients 
stem from previous experience from SARS-CoV, which posed a particular risk to healthcare 
workers as peak viral load tended to occur 7-10 days post-infection 10. In contrast, COVID-19 
patients appear to have the highest viral load at the onset of infection and this subsequently 
declines over time, which may account for the speed at which this novel coronavirus is 
spreading within the community 11. Furthermore, although it has been shown that SARS-
CoV-2 RNA can be detected in patients up to 20 days or longer post-infection, it is unclear 
whether this represents patients shedding live virus, or if this reflects shedded virions 
inactivated by host antibodies 11. In the context of planning a tracheotomy, this has two 
important implications; first, a positive test does not reflect the degree of infectivity of a 
patient, and second, on the basis of current data we can draw a cautious degree of 
reassurance that patients are likely to be less infectious the further away they are from their 
initial presentation. Thus, we believe that undertaking a tracheotomy at least 14 days 
following a positive swab result, in conjunction with wearing full Personal Protective 
Equipment (PPE) and taking all the necessary steps to minimize aerosolization peri-
tracheotomy insertion (see Supplementary Material) presents a pragmatic solution to 
minimizing risk to staff. To date, none of the OR staff who have been involved with 
undertaking tracheotomies in COVID-19 patients has tested positive for the disease in our 
institution.  
 
In light of the relative uncertainties that exist in the treatment of patients with COVID-19, 
patient selection for tracheotomy will ultimately be refined through experience. The 
selection criteria proposed in this study (FiO2≤50% and PEEP≤8cm of H2O in the 24 hours 
prior to the tracheotomy) were derived on the basis of our early experience with the first 
five COVID-19 tracheotomies; of which, one survived (patient A), two died (patients B and C) 
and the remaining two had a prolonged wean off the ventilator (patient D, who was taken 
off ventilation at day 17 post-procedure, and patient E, who continues to be on ventilation 
at the time of writing). Of the 4 patients who had less favorable outcomes, three had either 
an FiO2≥50% or a PEEP requirement exceeding 8cm H2O. The ‘anomaly’ was patient C who 
despite being within an acceptable range for both FiO2 and PEEP unfortunately died. In 
retrospect, this patient probably had their tracheostomy too early at day 4 post-intubation; 
it is thus vital that ICU teams liaise closely with surgical teams when identifying potential 
candidates for tracheotomy, and put forward those patients who have demonstrated 
improvement in their clinical course.   
 
From this study, two important findings emerge in terms of the prognostic value of 
ventilation-related parameters prior to tracheotomy.  These are an FiO2 requirement ≤50% 
and PEEP≤8cm H2O in the 24 hours prior to tracheotomy with all patients exceeding these 
cut off values either experiencing a prolonged wean and dying or failing to improve and 
continuing to require ICU support. Satisfying both the FiO2 and PEEP criteria is equally 
important when considering tracheotomy in COVID-19 patients failing trial(s) of extubation. 
The case of patient D illustrates why consideration of FiO2 requirements alone is not 
adequate when it comes to COVID-19 patients. Even if pre-operative FiO2 requirements 
remain below the 50% cut off, COVID-19 patients are unlikely to do well following 
tracheotomy if their PEEP requirements exceed 8cm H2O. The reason is that the high PEEP 
dependence makes them less able to tolerate the combination of a reduction in FiO2 to 21% 
during tracheal exposure and the subsequent cessation of ventilation prior to tube 
exchange, both key recommendation for tracheotomy in COVID-19 patients. 12  
 
Furthermore, we have demonstrated that there is a correlation (ρ=0. 955, p<0.05) between 
the proportion of time patients’ PEEP values are ≤8cm H2O and their FiO2 values are ≤50% in 
the first 48 hours following tracheotomy with the respective values (ventilation 
requirements) across all days of their stay in critical care.  This is of clinical importance 
because it could potentially permit prognostication through early risk-stratification; with 
those patients whose ventilator requirements consistently remain below the described cut 
off values (i.e. FiO2≤50% and PEEP≤8cm of H2O) for the first 2 post-operative days to 
represent a subgroup that can potentially be safely stepped down to another clinical area 
outside the ICU environment at that stage. This has the potential of freeing up intensive 
care beds as early as day 2 post-tracheotomy for other patients that need it more. 
Furthermore, with the emergence of field hospitals to help cope with the increased patient 
demand from the COVID-19 pandemic, this could assist in identifying those patients who 
following tracheotomy are suitable for transfer to such facilities, further enhancing ICU 
capacity, a precious and limited resource in the fight against COVID-19.  
 
Prior to concluding, it is important to consider the strengths and limitations of this study. 
The key limitation relates to the small number of patients (n=12). Another relates to the 
novelty of the disease studied meaning that it is likely that further refinements to the 
proposed criteria  will be needed in the future as our understanding of the pathophysiology 
of COVID-19 evolves. Finally, only two prognostic parameters were studied. Despite these 
limitations, this study also features a number of key strengths. It is the first to look into the 
development of formal selection criteria for tracheotomy in ventilated patients with COVID-
19 and the first to determine early prognostic factors for these patients. Moreover, this has 
been done in a quantitative manner. By providing actual cut off values for pre- and post-
tracheotomy ventilatory requirements, it facilitates patient selection, permits risk 
stratification and in doing so can directly assist clinical decision-making and inform policy.   
 
In conclusion, this study presents for the first time measurable patient selection criteria for 
tracheotomy in COVID-19 patients, illustrating that an FiO2≤50 % and PEEP≤8cm H20 in the 
24 hours prior to tracheotomy are useful markers in helping to identify those patients that 
are most likely to benefit from a tracheotomy. It has also shown that patients that are able 
to remain below these threshold values in the first 48 hours following tracheotomy are 
likely to exhibit a favourable outcome and can thus be stepped down from an intensive care 
setting at that (early) stage, freeing up vital capacity for other critically ill COVID-19 patients 
in need of urgent ICU care.  
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Table 1: Summary table outlining patient demographics, comorbidities, ventilatory 
requirements, and patient outcomes.  
  










Current Status Days 
followed up 
A 51 Type 2 Diabetes, 
Hypertension 
41-50 5 None Discharged 12 
days post op 
12 
 
B 76 Previous 
pneumothorax and 
pleurodesis 
81-90 6 Tube 
displacement 
Deceased 4 days 
post op 
4 
C 63 Myocardial 
Infarction >20 years 
ago 




D 60 Type 2 Diabetes, 
Hypertension 









F 54 Lupus, Asthma 41-50 
 
8 None Discharged ITU 
day 11 
11 
G 75 Osteoarthritis, 
Hypertension 
31-40 5 None Discharged ITU 
day 13 
13 
H 61 MI and PCI <10 years 
ago, Type 2 
Diabetes, 
Hypertension 
20-29 6 None Discharged ITU 
day 11 
11 
I 66 PE and MI with Stent 
< 10 years 
30-39 6 None Decannulated 
day 8 
8 
J 61 Nil Past medical 
history 
20-29 5 None Discharged ITU 
day 6 
6 
K 59 Asthma, under 
investigation for 
COPD/ Fibrosis 
40-49 8 None Off sedation day 
6 
6 
L 68 Mastectomy and 
Radiotherapy 






Figure 1: Bubble plot plotting average sustained FiO2 in the 24 hours preceding tracheostomy 
(measured in %10) and PEEP in cm H20 (represented by bubble diameter and number within bubble, 
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Figure 2:  Patient rank according to average proportion of time FiO2≥50% and PEEP≥8 cm H20 at end 
of patient follow up (y-axis) plotted against patient rank according to average proportion of time 


































Total no. of days 
data 





No. times PEEP 
> or equal to 8 
Proportion PEEP 
> or equal to 8 
No. times FiO2 
Greater or equal 
to 50% 
Proportion FiO2 




A 7 9 0 0.00 1 0.11 0.06 3 
B 3 5 3 0.60 5 1.00 0.80 12 
C 5 7 7 1.00 4 0.57 0.79 11 
D 21 23 12 0.52 9 0.39 0.46 9 
E 17 19 1 0.05 3 0.16 0.11 5 
F 9 11 3 0.27 0 0.00 0.14 6 
G 11 13 0 0.00 0 0.00 0.00 1 
H 9 11 2 0.18 1 0.09 0.14 6 
I 7 9 0 0.00 1 0.11 0.06 3 
J 5 7 0 0.00 0 0.00 0.00 1 
K 6 8 2 0.25 2 0.25 0.25 8 
 











Patient 4 days data 
No. times PEEP 
> or equal to 8 
Proportion PEEP 
> or equal to 8 
No. times FiO2 
Greater or 
equal to 50% 
Proportion FiO2 




A 0 0.00 1 0.25 0.13 3 
B 2 0.50 4 1.00 0.75 12 
C 4 1.00 1 0.25 0.63 10 
D 2 0.50 1 0.25 0.38 6 
E 1 0.25 2 0.50 0.38 6 
F 3 0.75 0 0.00 0.38 6 
G 0 0.00 0 0.00 0.00 1 
H 2 0.50 0 0.00 0.25 5 
I 0 0.00 1 0.25 0.13 3 
J 0 0.00 0 0.00 0.00 1 
K 1 0.25 2 0.50 0.38 6 
 
 
Supplementary Table 2: Calculations for proportion of time FIO2 above 50% and PEEP above 8cmH2O and ranking for first 4 days (day -1 to day 2) 
 
